S-2837 : Still Just a Bill

Preventing Drug Diversion Act of 2018

This bill establishes a new requirement intended to help drug manufacturers and distributors identify and prevent suspicious orders of opioids and reduce rates of diversion.

Specifically, the Drug Enforcement Administration must use its automated data system—the Automated Reports and Consolidated Ordering System—to inform drug manufacturers and distributors about the quantity and type of opioids that are distributed to pharmacies and practitioners.

Additionally, the bill establishes new requirements for reporting, collecting, and sharing information about suspicious orders.

Action Timeline

Action DateTypeTextSource
2018-06-19CalendarsPlaced on Senate Legislative Calendar under General Orders. Calendar No. 471.Senate
2018-06-19CommitteeCommittee on the Judiciary. Reported by Senator Grassley with an amendment in the nature of a substitute. Without written report.Senate
2018-06-14CommitteeCommittee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably.Senate
2018-05-14IntroReferralRead twice and referred to the Committee on the Judiciary.Senate
2018-05-14IntroReferralIntroduced in SenateLibrary of Congress

Policy Area :

Crime and Law Enforcement
See Subjects
  • Administrative law and regulatory procedures
  • Business records
  • Civil actions and liability
  • Congressional oversight
  • Criminal investigation, prosecution, interrogation
  • Criminal justice information and records
  • Department of Justice
  • Drug trafficking and controlled substances
  • Intergovernmental relations
  • Licensing and registrations
  • Retail and wholesale trades
  • State and local government operations

Related Bills

See Related Bills